← Back to Search
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Ann Arbor, MI
N/A
Waitlist Available
Led By Susan Murphy, ScD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change over 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to determine the feasibility and preliminary effects of a novel treatment approach to improve arm function in patients with scleroderma who have upper extremity contractures. It is a Phase 1, one arm trial in which participants will be assessed at baseline, 4 weeks, and 8 weeks. The rehabilitation intervention will involve 8 individual sessions with an occupational therapist. Feasibility of the procedures is a major focus of this project.
See full description
Eligible Conditions
- Systemic sclerosis
- Scleroderma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change over 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change over 8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
quickDASH
Secondary study objectives
Coordination
Grip Strength
Physical Function
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Occupational therapy treatmentExperimental Treatment1 Intervention
Participants will undergo the following as appropriate:
1. Thermal Modalities Hot packs, focused on areas with limitations Paraffin, focused on digital limitations
2. Application of the Physiotouch (a low-intensity negative pressure device)
3. Passive Range of Motion
4. Active Range of Motion
5. Functional Activities
Find a Location
Closest Location:University of Michigan· Ann Arbor, MI
Who is running the clinical trial?
University of MichiganLead Sponsor
1,879 Previous Clinical Trials
6,456,806 Total Patients Enrolled
10 Trials studying Scleroderma
744 Patients Enrolled for Scleroderma
University of Alabama at BirminghamOTHER
1,664 Previous Clinical Trials
2,450,905 Total Patients Enrolled
2 Trials studying Scleroderma
40,168 Patients Enrolled for Scleroderma
Susan Murphy, ScDPrincipal InvestigatorUniversity of Michigan - Department of Physical Medicine and Rehabilitation